Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04068415
Other study ID # CHUBX 2010/44
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 6, 2012
Est. completion date April 16, 2014

Study information

Verified date August 2019
Source University Hospital, Bordeaux
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Develop a risk assessment scale for constipation of hospitalized patients to identify at an early stage high-risk individuals and to implement the appropriate means of prevention.


Description:

Constipation remains a prominent problem in the hospital care setting given the accumulation of contributing factors. Indeed, one of the most common causes of constipation is the existence of irregular habits in stool schedules, including the fact of delaying the time to go to the toilet, which causes the subject for a prolonged period of time to inhibit symptoms. defecation reflexes.

These disorders are often increased by the lack of exercise and prolonged bed rest, which cause a lack of muscle of the abdominal strap, the abdominals not being able to play their role of compression.

Some drugs are also a major cause of the difficulty of intestinal elimination, including opiates, anticholinergics, anti-depressants, etc.

Finally, an unbalanced diet, a water deficiency are aggravating factors, as is anxiety. In the medical and para-medical literature, there is no complete and validated tool for assessing the risk of constipation at the admission of a hospital stay. This project is to develop a constipation risk assessment scale, which can be used autonomously by nurses, based on the risk factors identified in the literature, scales published in English, and 2007 recommendations from the French National Society of Gastroenterology, recommendations of the High Authority of Health and a consensus of experts. The use of such a tool would make it possible to identify at an early stage high-risk individuals and to implement the appropriate means of prevention.


Recruitment information / eligibility

Status Completed
Enrollment 516
Est. completion date April 16, 2014
Est. primary completion date April 16, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female 18 years or older

- Swallowing, drinking and eating

- Hospitalized in one of the participating services

- Hospitalized for a period of at least 4 days

- Able to give informed consent and answer questions about his or her lifestyle

Exclusion Criteria:

- Patient with major constipation at baseline (no stool for at least 6 days)

- History of intestinal surgery during the 10 days preceding the study,

- Hospitalized in palliative care or bed identified palliative care.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Constipation risk assessment scale
questionnaires

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Bordeaux

Outcome

Type Measure Description Time frame Safety issue
Primary Constipation yes/no Less than a saddle in the first 4 days and prescription of laxatives On the 4th day of hospitalization
See also
  Status Clinical Trial Phase
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Recruiting NCT06292949 - Clinical Study of Resistant Starch in Improving Constipation N/A
Recruiting NCT04132661 - MRI Assessment of Mode of Action of Bisacodyl, Single Dose Phase 4
Terminated NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Phase 4
Completed NCT02726295 - The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study Phase 4
Recruiting NCT02255747 - Anal Dilatation for Infants and Children With Constipation N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Completed NCT01566409 - Maintenance Treatment for Children With Constipation N/A
Completed NCT02863848 - Effect of Inulin-type Fructans on Constipated Children. N/A
Completed NCT01695915 - Diurnal Variation in Rectal Diameter N/A
Completed NCT01710579 - Normal Values in Ano-rectal 3D High Resolution Manometry N/A
Completed NCT02658201 - Ultrafast MRI Imaging to Exclude Constipation N/A
Completed NCT01474499 - A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation Phase 3
Completed NCT01438567 - A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy Phase 3
Completed NCT01411501 - Efficacy and Safety of Acupuncture for Functional Constipation Phase 3
Completed NCT00931853 - Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC). Phase 3
Completed NCT01170039 - The Effectiveness of Lubiprostone in Constipated Diabetics Phase 4
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4
Completed NCT00994851 - Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment. Phase 3